Pharmacological properties of 1-(3'5'-diisobutyryloxy-phenyl)-2-(t-butylamino)-ethanolhydrochloride (KWD 2058), a new sympathomimetic bronchodilator.
D000284:Administration, Oral; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D002087:Butyrates / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D003864:Depression, Chemical; D004353:Drug Evaluation, Preclinical; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D013726:Terbutaline / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D014132:Trachea / Q000187:drug effects
D001993:Bronchodilator Agents; D002087:Butyrates; D013726:Terbutaline